Nature Communications (Aug 2022)

Molecular characterization of colorectal cancer related peritoneal metastatic disease

  • Kristiaan J. Lenos,
  • Sander Bach,
  • Leandro Ferreira Moreno,
  • Sanne ten Hoorn,
  • Nina R. Sluiter,
  • Sanne Bootsma,
  • Felipe A. Vieira Braga,
  • Lisanne E. Nijman,
  • Tom van den Bosch,
  • Daniel M. Miedema,
  • Erik van Dijk,
  • Bauke Ylstra,
  • Ruth Kulicke,
  • Fred P. Davis,
  • Nicolas Stransky,
  • Gromoslaw A. Smolen,
  • Robert R. J. Coebergh van den Braak,
  • Jan N. M. IJzermans,
  • John W. M. Martens,
  • Sally Hallam,
  • Andrew D. Beggs,
  • Geert J. P. L. Kops,
  • Nico Lansu,
  • Vivian P. Bastiaenen,
  • Charlotte E. L. Klaver,
  • Maria C. Lecca,
  • Khalid El Makrini,
  • Clara C. Elbers,
  • Mark P. G. Dings,
  • Carel J. M. van Noesel,
  • Onno Kranenburg,
  • Jan Paul Medema,
  • Jan Koster,
  • Lianne Koens,
  • Cornelis J. A. Punt,
  • Pieter J. Tanis,
  • Ignace H. de Hingh,
  • Maarten F. Bijlsma,
  • Jurriaan B. Tuynman,
  • Louis Vermeulen

DOI
https://doi.org/10.1038/s41467-022-32198-z
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 14

Abstract

Read online

Colorectal cancer can lead to the development of peritoneal metastases, which are associated with worse disease outcome. Here, the authors characterize peritoneal metastases from 52 patients using RNA-seq and mutational sequencing and show a distinct molecular subtype.